BridgeBio Pharma, Inc. · NASDAQ:BBIO
Kumar Neil exercised options for 71,216 BridgeBio Pharma, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Kumar Neil (Director, Chief Executive Officer) exercised options for 71,216 BridgeBio Pharma, Inc. shares, leaving 278,307 shares. Filed Nov 18, 2026 (Form 4).
- Options exercised
- 71,216 shares
- Holding after
- 278,307 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Option exercise | 33,544 | 276,871 | Direct | |
| Nov 16, 2026 | Common Stock | Option exercise | 19,599 | 296,470 | Direct | |
| Nov 16, 2026 | Common Stock | Option exercise | 11,554 | 308,024 | Direct | |
| Nov 16, 2026 | Common Stock | Option exercise | 6,519 | 314,543 | Direct | |
| Nov 16, 2026 | Common Stock | Shares withheld for tax | 36,236 | US$77.36 | 278,307 | Direct |
Source
Download original · View original at SEC
Related
- BridgeBio Pharma, Inc.
- Kumar Neil
- BridgeBio Pharma, Inc. shareholders
- Form 4 · Kumar Neil · Nov 20, 2026
- Form 4 · Kumar Neil · Sep 21, 2026
- Form 4 · Kumar Neil · Aug 20, 2026
- Form 4 · Kumar Neil · Aug 18, 2026
- Form 4 · Kumar Neil · Jun 8, 2026
- Form 4 · Apuli Maricel · Nov 18, 2026
- Form 4 · Trimarchi Thomas · Nov 18, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 12, 2026
- Form 4 · Apuli Maricel · Nov 3, 2026
- Schedule 13G · BlackRock, Inc. · Oct 27, 2026